ASCO Gu 2025: real world data confirm... - Fight Prostate Ca...

Fight Prostate Cancer

2,985 members1,361 posts

ASCO Gu 2025: real world data confirms that undetectable PSA nadir is a strong predictor of outcomes

Maxone73 profile image
17 Replies

Real world seems to confirm clinical trial data in this case!

A real-world study from the IRONMAN registry confirms that achieving an undetectable PSA nadir (<0.2 ng/mL) within the first year of treatment is linked to better long-term outcomes in metastatic hormone-sensitive prostate cancer (mHSPC). Among 1,377 patients, those treated with ADT + ARPI had the highest PSA suppression rates (51% at 6 months, 63% at 12 months), outperforming ADT alone (27% and 38%) and ADT + docetaxel (26% and 32%).

After a median follow-up of 18 months, 21% of patients experienced disease relapse, with lower relapse rates in those who reached PSA nadir <0.2 ng/mL at 6 months.

prostatewarriors.com/2025/0...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
17 Replies
Scout4answers profile image
Scout4answers

awesome. Can we buy these as a supplement or do we need to buy them individually?

Maxone73 profile image
Maxone73 in reply toScout4answers

Mmmm...I think you missed the right post!

Scout4answers profile image
Scout4answers in reply toMaxone73

Yes

janebob99 profile image
janebob99

Excellent! Thanks for the posting.

pakb profile image
pakb

My husband is an outlier in this. He's never been below .8 PSA. started at >677 (urologist gave him bicalutimide for 2 weeks prior to doing 1st PSA- crazy, I know). After lupron and 6 rounds chemo got down to 25. Then took 6 years to get down to .8. Fluctuated for those 6 years- sometimes up a point or bit then back down. Mostly has hovered between 1 and 2 the last 2 years. He went to lupron and abiraterone +prednisone after chemo and has been on that for 7 years. Spot radiation to previous metastasis site on spine that re-lit up 2x in last 3 years. No symptoms since chemo at diagnosis.

Maxone73 profile image
Maxone73 in reply topakb

I think that if you have a slow but steady decrease in PSA during the years could be even better!

dhccpa profile image
dhccpa

I was diagnosed as metastatic in 2018 and have spent 6.5 years on Lupron alone, no ARPI. No RP or radiation at that time.

Nadir was 0.5 in April 2021 (one reading, but I've had 7-8 readings of 0.6).

I just finished radiation to prostate and pelvis on 1/22 and PSA was 0.56 on 2/6 (down from high of 2.72 on 10/5/2024).

I've never been clear on how low PSA could go on just Lupron with a functioning prostate. Any idea?

Maxone73 profile image
Maxone73 in reply todhccpa

Very hard to answer!

Orange95 profile image
Orange95 in reply todhccpa

My husband’s readings PSA 56June/24 pretreatment, first Lupron end of June, PSA 0,3 September/24 second Lupron, PSA 0,09 December/24. Completed 20 RT sessions in December. Next PSA test next week. Also the plan to add ARPI

dhccpa profile image
dhccpa in reply toOrange95

That's low if prostate functioning and just Lupron. December reading after at least some or all radiation?

Orange95 profile image
Orange95 in reply todhccpa

that was at the beginning of RT, after 2 sessions.

dhccpa profile image
dhccpa

Yes, you're right.

Maxone73 profile image
Maxone73 in reply todhccpa

With adt + arpi and a prostate i am at 0.01 currently

dhccpa profile image
dhccpa in reply toMaxone73

I'm anxious for this recent radiation to play out. It's very early yet, but I was encouraged by the reading. Of course, one hopes the radiation was done as effectively as possible.

dhccpa profile image
dhccpa

I do encourage everyone, including those going to "center of excellence," to bring these results to your doctors and get their reactions and report back. I've done it with my three, none of whom could be fairly called a prostate cancer expert. They seem scared to death, but that didn't surprise me.

Probably best to emphasize that you're not demanding estrogen therapy at present, just following these breaking developments and wanting to encourage them to follow them also.

Just a suggestion for anyone interested in this therapy.

Adendino profile image
Adendino

I'm not sure how this study plays into the various types of PSA testing. My husband's doc uses ultrasensitive PSA tests and after EMRT + ADT + Abiraterone for 2 yrs he got down to .02, but it didn't have the < sign because the test was so sensitive so he technically wasn't undetectable.

Maxone73 profile image
Maxone73 in reply toAdendino

"undetectable PSA nadir (<0.2 ng/mL)" so for the parameters used for this study your husband is undetectable since he is 10 times lower than that 😀

Not what you're looking for?

You may also like...

ASCO GU 2025: new data confirms triplet therapy benefits, especially with darolutamide

A new population-adjusted analysis confirms that the combination of darolutamide, ADT, and...
Maxone73 profile image

Early (but not too early) PSA drop is a predictor of ADT efficacy (+ apalutamide)

Early PSA response at 6 months is both a predictor and a causal mediator of treatment efficacy for...
Maxone73 profile image

ASCO GU 2025: factors that lead to a faster castrations resistance

With all the limits of a retrospective study (otherwise I might almost become depressed...) A...
Maxone73 profile image

Skin Patches vs. Traditional Hormone Therapy: A New Option for Metastatic Prostate Cancer?

I feel like...we will soon be all moved to estradiol! A phase 2 study from the STAMPEDE trial...
Maxone73 profile image

Phase 2 trial: adaptive ADT for metastatic castration sensitive prostate cancer

The H. Lee Moffitt Cancer Center is advancing prostate cancer treatment with a Phase 2 trial...
Maxone73 profile image